Previous studies demonstrated that leptin treatment attenuated insulin resistance in genetically diabetic mice (such as ob/ob mice and MKR mice) [23,24] and in lipodystrophy model transgenic mice (such as aP2-SREBP-1c mice) [25]. Here, SREBF1 is linked to lipodystrophy.